Funds Shift, Market Rally, Analyst Upgrades: Hong Kong Stocks in Focus
HK:0005.HK:HSBC HOLDINGS
Morgan Stanley said funds are flowing back to Hong Kong-listed shares from US markets among dual primary listed firms. Cathy Zhang, Head of APAC Equity Capital Markets, highlighted that trading volume in Hong Kong rose to 36%, reflecting stronger investor preference for H-shares.
HK:3115.HK:HANGSENG INDEX
The Hang Seng Index (HSI) surged 359 points or 1.4% to close at 25,417, boosted by expectations of new policy measures to expand service consumption in mainland China. Gains were led by chip, photovoltaic, pharmaceutical, and metal stocks.
HK:02252.HK:MEDBOT-B
Jefferies raised its target price for MEDBOT-B to US$35, citing strong visibility from new overseas orders. The company secured more than 30 units in 1H25, nearly hitting its full-year guidance of 40 units, while management maintained an 85% revenue growth forecast.
HK:0960.HK:LONGFOR GROUP / HK:0101.HK:HANG LUNG PPT / HK:0700.HK:TENCENT
Morgan Stanley expects Hang Lung Properties’ share price to outperform the market over the next 60 days. Separately, Tencent canceled its Zenvideo cloud video creation platform accounts, while Longfor Group was highlighted in multiple analyst reports post-results.
HK:2318.HK:PING AN INSURANCE / HK:0966.HK:CHINA TAIPING
BOCOM International raised its target price on China Taiping to $20 with a Buy rating. Meanwhile, multiple research houses — including Citi and UBS — updated views on Sun Hung Kai Properties (HK:0016.HK:SHK PPT), keeping mixed ratings ranging from Buy to Neutral.
HK:9988.HK:ALIBABA
Alibaba’s Hong Kong-listed arm offloaded its stake in SGX:S08.SI:Singapore Post for SGD65 million in cash, according to reports.
HK:1211.HK:BYD COMPANY / HK:LKNCY:Luckin Coffee
BYD’s FangChengBao unit partnered with Luckin Coffee to roll out in-car coffee ordering, expanding its smart mobility offerings.
HK:3690.HK:MEITUAN-W
Fitch Ratings revised down Meituan’s outlook to Stable from Positive, citing unsustainable competition in its food delivery segment.
HK:941.HK:CHINA MOBILE
HSBC Research reiterated China Mobile as its top pick, noting that commercial 6G launch remains at least five years away.
Pharma Deals, Tech Expansions, and Corporate Moves Drive Headlines
HK:600276.SS:HENGRUI PHARMA
Hengrui Pharma granted Braveheart Bio commercialization rights for its drug candidate HRS-1893, expanding its international licensing footprint.
HK:2121.HK:AINNOVATION
AI company AInnovation said it expects to achieve profitability by 2026 at the earliest and is exploring opportunities in the Middle East market.
US:SBUX:STARBUCKS
Starbucks has reportedly received bids for its China business stake, valued at around US$5 billion, as the coffee giant explores strategic options.
HK:1810.HK:XIAOMI-W
Xiaomi unveiled its electric SUV, the Xiaomi YU7, in Hong Kong, marking its formal entry into the EV market.
HK:0005.HK:HSBC HOLDINGS
HSBC repurchased over 3.82 million shares yesterday, with the buyback valued at HKD383 million.
HK:9988.HK:BABA-W
Alibaba commenced an exchange offer for its outstanding senior notes worth US$2.65 billion, continuing to manage its debt profile.
Than you
